PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Opioid Epidemiology and Policy, Department of Population Health, New York University Grossman School of Medicine, New York, NY 10016, USA.\', \'Section on Tobacco, Alcohol, and Drug Use, Division of Comparative Effectiveness and Decision Science, Department of Population Health, New York University Grossman School of Medicine, New York, NY 10016, USA.\', \'VA NY Harbor Healthcare System, New York, NY 10010, USA.\', \'Division of Infectious Diseases, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA.\', \'Department of Infection Prevention and Control, NYU Langone Health, New York, NY 10016, USA.\', \'Division of Comparative Effectiveness and Decision Science, Department of Population Health, New York University Grossman School of Medicine, New York, NY 10016, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/pubmed/fdaa241
?:doi
?:hasPublicationType
?:journal
  • Journal of public health (Oxford, England)
is ?:pmid of
?:pmid
?:pmid
  • 33367823
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Association of substance use disorders and drug overdose with adverse COVID-19 outcomes in New York City: January-October 2020.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all